Clinical utility gene card for: Familial Hypobetalipoproteinaemia (APOB)

European Journal of Human Genetics

Volumn 20, Issue 8, 2012, Pages 909-

  Burnett, John R ^a,b,c   Bell, Damon A ^a,b   Hooper, Amanda J ^a,b,c   Hegele, Robert A ^d  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABETALIPOPROTEINEMIA; APOB GENE; ARTICLE; DNA SEQUENCE; EXON; GENE; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; INTRON; MISSENSE MUTATION; MTTP GENE; NONSENSE MUTATION; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; GENETIC SCREENING; GENETICS; HYPOBETALIPOPROTEINEMIA; METHODOLOGY; MUTATION;

APOLIPOPROTEINS B; GENETIC TESTING; GENOTYPE; HUMANS; HYPOBETALIPOPROTEINEMIAS; MUTATION; SENSITIVITY AND SPECIFICITY;

EID: 84864127581     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.85     Document Type: Article

References (11)

1. Kane JP, Havel RJ: Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins; in Scriver CR, Beaudet AL, Sly WS et al (eds): The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001; 8th edn, pp 2717-2752.
2. Hooper AJ, van Bockxmeer FM, Burnett JR: Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism. Crit Rev Clin Lab Sci 2005; 42: 515-545. (Pubitemid 43068251)
3. Tarugi P, Averna M: Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. Adv Clin Chem 2011; 54: 81-107.
4. Burnett JR, Zhong S, Jiang ZG et al: Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia. J Biol Chem 2007; 282: 24270-24283. (Pubitemid 47328026)
5. Welty FK, Lahoz C, Tucker KL, Ordovas JM, Wilson PW, Schaefer EJ: Frequency of apoB and apoE gene mutations as causes of hypobetalipoproteinemia in the Framingham offspring population. Arterioscler Thromb Vasc Biol 1998; 18: 1745-1751. (Pubitemid 28521064)
6. Hooper AJ, Adams LA, Burnett JR: Genetic determinants of hepatic steatosis in man. J Lipid Res 2011; 52: 593-617.
7. Schonfeld G, Patterson BW, Yablonskiy DA et al: Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. J Lipid Res 2003; 44: 470-478. (Pubitemid 37279694)
8. Clarke MW, Hooper AJ, Headlam HA et al: Assessment of tocopherol metabolism and oxidative stress in familial hypobetalipoproteinemia. Clin Chem 2006; 52: 1339-1345. (Pubitemid 43956026)
9. Chowers I, Banin E, Merin S et al: Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients. Eye 2001; 15: 525-530. (Pubitemid 32755726)
10. Tarugi P, Lonardo A, Ballarini G et al: A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5). J Hepatol 2000; 33: 361-370. (Pubitemid 30663372)
11. Lonardo A, Tarugi P, Ballarini G, Bagni A: Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma. Dig Dis Sci 1998; 43: 2489-2492. (Pubitemid 28531325)